|
A look at the effects of bisphosphonates and the benefits it offers in treating bone loss.
Publication: M2 Presswire Publication Date: 31-JAN-06 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2006 Ingram Investment Ltd.
M2 PRESSWIRE-31 January 2006-Research and Markets: A look at the effects of bisphosphonates and the benefits it offers in treating bone loss.(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:07022006
Dublin: Research and Markets (http://www.researchandmarkets.com/reports/c31992) has announced the addition of Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer to their offering
Bisphosphonates have been in use for approximately 25 years, most commonly to treat diseases characterized by bone loss, such as osteoporosis. Bisphosphonates are also used in adjunctive treatment of cancers that involve bone-related complications. Currently, bisphosphonates are approved only for the treatment of patients with advanced...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from M2 Presswire |
A look into consumer activities and market trends for the household cl...
February 02, 2006
|
The market for OTC healthcare products reached SEK6 billion in Sweden.
February 02, 2006
|
Understand the competitive environment within the Cough, Cold and Alle...
February 02, 2006
|
AstraZeneca, GlaxoSmithKline (GSK), Pfizer, and Sanofi-Aventis the fou...
February 02, 2006
|
Promoting integration through education: new website for refugees in t...
February 07, 2006
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
